We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Overhaul Bill Clears U.S. House Panel, Heads to Floor Vote
FDA Overhaul Bill Clears U.S. House Panel, Heads to Floor Vote
The House Energy & Commerce Committee passed the 21st Century Cures Act on May 21, a measure that would extend the rare pediatric disease priority review voucher program from its current sunset date in March 2016 through December 2018.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor